Imported tropical diseases

Dermatologic Therapy

Volumn 22, Issue 6, 2009, Pages 538-549

  Patel, Shaily ^a   Sethi, Aisha ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Disease; Imported; Skin; Treatment; Tropical

Indexed keywords

ALBENDAZOLE; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN; ANTIHISTAMINIC AGENT; ANTIMONY; BENZNIDAZOLE; CALAMINE; CARBAPENEM DERIVATIVE; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; GRISEOFULVIN; IMIPENEM; ITRACONAZOLE; IVERMECTIN; KETOCONAZOLE; NIFURTIMOX; OXAZOLIDINONE DERIVATIVE; POSACONAZOLE; PRAZIQUANTEL; PYRROLE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TERBINAFINE; TETRACYCLINE; TIABENDAZOLE; UNINDEXED DRUG; VORICONAZOLE;

ACTINOMYCETOMA; ANCYLOSTOMA CANINUM; ANCYLOSTOMIASIS; AWARENESS; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CERCARIAL DERMATITIS; CHAGAS DISEASE; CLOTHING; CRYOTHERAPY; CUTANEOUS LARVA MIGRANS; DENGUE; DERMATITIS; DERMATOBIA; DIZZINESS; DRUG ERUPTION; DRUG MEGADOSE; EDEMA; EUMYCETOMA; FATIGUE; FOLLICULITIS; FREEZING; GASTROINTESTINAL DISEASE; GEL; HEADACHE; HEALTH CARE PERSONNEL; HEPATITIS; HUMAN; HYGIENE; HYPEREOSINOPHILIA; IMMIGRANT; IMPETIGO; LABORATORY TEST; LEISHMANIA; LEISHMANIASIS; LUNG DISEASE; MORBIDITY; MORTALITY; MYALGIA; MYCETOMA; MYIASIS; NAUSEA; NONHUMAN; PANCREATITIS; PHYSICAL EXAMINATION; POSTOPERATIVE INFECTION; QT PROLONGATION; REVIEW; SCHISTOSOMA; SCHISTOSOMIASIS; SINGLE DRUG DOSE; TROPICAL DISEASE; TRYPANOSOMA CRUZI; VOMITING;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIPARASITIC AGENTS; ANTIVIRAL AGENTS; HUMANS; SKIN DISEASES, INFECTIOUS; TRAVEL; TROPICAL CLIMATE;

EID: 70449367121     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2009.01275.x     Document Type: Review

References (85)

1. Monsel G, Caumes E. Recent developments in dermatological syndromes in returning travelers. Curr Opin Infect Dis 2008 : 21 (5 495 499.
2. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006 : 354 : 119 130.
3. O'Brien BM. A practical approach to common skin problems in returning travelers. Travel Med Infect Dis 2009 : 7 (3 125 146.
4. Hochedez P, Caumes E. Common skin infections in travelers. J Travel Med 2008 : 15 : 223 233.
5. Lupi O. Protozoa and worms. In : Bolgnia JL, Jorizzo JL, Rapini RP, eds. Dermatology, 2nd ed. London : Mosby, 2008 : 1263 1289.
6. Caumes E, Carriere J, Guermonprez G, Bricaire F, Danis M, Gentilini M. Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin Infect Dis 1995 : 20 : 542 548.
7. Davies HD, Sakuls P, Keystone JS. Creeping eruption. A review of clinical presentation and management of 60 cases presented to a tropical disease unit. Arch Dermatol 1993 : 129 : 588 591.
8. Caumes E. Treament of cutaneous larva migrans. Clin Infect Dis 2000 : 30 : 811 814.
9. Bouchaud O, Houze S, Schiemann R, et al. Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin. Clin Infect Dis 2000 : 31 : 493 498.
10. Roest M, Ratnavel R. Cutaneous larva migrans contracted in England: a reminder. Clin Exp Dermatol 2001 : 26 : 389 390.
11. Jelinek T, Maiwald H, Nothdurft HD, Loscher T. Cutaneous larva migrans in travelers: synopsis of histories, symptoms and treatment of 98 patients. Clin Infect Dis 1994 : 19 : 1062 1066.
12. Butland RJ, Coulson IH. Pulmonary eosinophilia associated with cutaneous larva migrans. Thorax 1985 : 40 : 76 77.
13. Katz R, Ziegler J, Blank H. The natural course of creeping eruption and treatment with thiabendazole. Arch Dermatol 1965 : 91 : 420 424.
14. Stone OJ, Mullin JF. Thiabendazole effectiveness in creeping eruption. Arch Dermatol 1965 : 91 : 425 426.
15. Vakil BJ, Bandisode MS, Gaitonde BB, Salunkhe DS, Kulkarni HJ. Clinical trials with a new antihelminthic, thiabendazole. J Trop Med Hyg 1955 : 58 : 287 295.
16. Jones SK, Reynolds NJ, Oliwiecki S, Harman RRM. Oral albendazole for the treatment of cutaneous larva migrans. Br J Dermatol 1990 : 122 : 99 101.
17. Caumes E, Carrier J, Datry A, Danis M, Gentilini M. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg 1993 : 49 : 641 644.
18. Elgart ML. Flies and myiasis. Dermatol Clin 1990 : 8 : 237 244.
19. McGraw TA, Turiansky MC. Cutaneous myiasis. J Am Acad Dermatol 2008 : 58 (6 907 926.
20. Safdar N, Young DK, Andes D. Autochthonous furuncular myiasis in the United States: case report and literature review. Clin Infect Dis 2003 : 36 : e73 e80.
21. Meinking TL, Burkhart CN, Burkhart CG, Elgart G. Infestations. In : Bolgnia JL, Jorizzo JL, Rapini RP, eds. Dermatology, 2nd ed. London : Mosby, 2008 : 1300 1301.
22. Johnston M, Dickinson G. An unexpected surprise in a common boil. J Emerg Med 1996 : 14 : 779 781.
23. Gordon PM, Hepburn NC, Williams AE, Bunney MH. Cutaneous myiasis due to Dermatobia hominis: a report of six cases. Br J Dermatol 1995 : 132 : 811 814.
24. Brewer TF, Wilson ME, Gonzalez E, Felenstine D. Bacon therapy and furuncular myiasis. JAMA 1993 : 270 : 2087 2088.
25. Boggild AK, Keystone JS, Kain KC. Furuncular myiasis: a simple and rapid method for extraction of intact Dermatobia hominis larvae. Clin Infect Dis 2002 : 35 : 336 338.
26. Loong PT, Lui H, Buck HW. Cutaneous myiasis: a simple and effective technique for extraction of Dermatobia hominis larvae. Int J Dermatol 1992 : 31 : 657 659.
27. De Tarso P, Pierre-Filho P, Minguini N, Pierre LM, Pierre AM. Use of ivermectin in the treatment of orbital myiasis caused by Cochliomyia hominivorax. Scand J Infect Dis 2004 : 36 : 503 505.
28. Osorio J, Moncada L, Molano A, Valderrama S, Gualtero S, Franco-Paredes C. Role of ivermectin in the treatment of severe orbital myiasis due to Cochliomyia hominivorax. Clin Infect Dis 2006 : 43 : e57 e59.
29. Corachan M. Schistosomiasis and international travel. Clin Infect Dis 2002 : 35 : 446 450.
30. Davis-Reed L, Theis JH. Cutaneous schistosomiasis: report of a case and review of the literature. J Am Acad Dermatol 2000 : 42 : 678 680.
31. Amer M. Cutaneous schistosomiasis. Dermatol Clin 1994 : 12 : 713 717.
32. Farrell AM. Ectopic cutaneous schistosomiasis: extragenital involvement with progressive upward spread. Br J Dermatol 1996 : 135 : 110 112.
33. Mulvihill CA, Burnett JW. Swimmer's itch: a cercarial dermatitis. Cutis 1990 : 46 : 211 213.
34. Hoeffler DF. Cercarial dermatitis. Arch Environ Health 1974 : 29 : 225 229.
35. King CH, Mahmoud AF. Drugs five years later: praziquantel. Ann Intern Med 1989 : 110 : 290 296.
36. Hay RJ, Maghoub ES, Leon G, et al. Mycetoma. J Med Vet Mycol 1992 : 30 (1 41 46.
37. Hay RR. Fungal infections. Clin Dermatol 2006 : 24 : 201 212.
38. Ameen M, Arenas R. Developments in the management of mycetomas. Clin Exp Dermatol 2009 : 34 : 1 7.
39. Tomecki KJ, Steck WD, Hall GS, Dijkstra JWE. Subcutaneous mycoses. J Am Acad Dermatol 1989 : 21 (4 785 790.
40. McGinnis MR. Mycetoma. Dermatol Clin 1996 : 14 (1 97 104.
41. Sobera JO, Elewski BE. Fungal diseases. In : Bolgnia JL, Jorizzo JL, Rapini RP, eds. Dermatology, 2nd ed. London : Mosby, 2008 : 1150 1152.
42. Maghoub ES. Treatment of actinomycetoma with sulphamethoxazole plus trimethoprim. Am J Trop Med Hyg 1972 : 21 : 332 335.
43. Mahgoub ES. Medical management of mycetoma. Bull World Health Organ 1976 : 54 : 3003 3311.
44. Welsch O, Sauceda E, Gonzalez J, Ocampo J. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J Am Acad Dermatol 1987 : 17 : 443 448.
45. Ramam M, Bhat R, Garg T, et al. A modified two-step treatment for actinomycetoma. Indian J Dermatol Venereol Leprol 2007 : 73 : 235 239.
46. Mahgoub ES, Gumaa SA. Ketoconazole in the treatment of eumycetomas due to Madurella mycetomii. Trans R Soc Trop Med Hyg 1984 : 78 : 376 379.
47. Venugopal PV, Venugopal TV. Treatment of eumycetomas with ketoconazole. Australas J Dermatol 1993 : 34 : 27 29.
48. Smith EL, Kutbi S. Improvement of eumycetomas with itraconazole. J Am Acad Dermatol 1997 : 34 : 279 280.
49. Castro LG, Piquero-Casals J. Clinical and mycologic findings and therapeutic outcome of 27 mycetoma patients from Sao Paulo, Brazil. Int J Dermatol 2008 : 47 : 160 163.
50. Welsh O, Salinas MC, Rodriguez MA. Treatment of eumycetomas and actinomycetoma. Curr Top Med Mycol 1995 : 6 : 47 71.
51. Restrepo A. Treatment of tropical mycoses. J Am Acad Dermatol 1994 : 31 (3 S91 S102.
52. Ligon BL. Dengue fever and dengue hemorrhagic fever: a review of the history, transmission, treatment and prevention. Semin Pediatr Infect Dis 2005 : 16 : 60 65.
53. Halstead SB. Dengue. Lancet 2007 : 370 : 1644 1652.
54. Jelinek T. Dengue fever in international travelers. Clin Infect Dis 2000 : 31 : 144 147.
55. Schwartz E, Mendelson E, Sidi Y. Dengue fever among travelers. Am J Med 1996 : 101 : 516 520.
56. Jelinek T, Dobler G, Holscher M, Loscher T, Nothdurft H. Prevalence of infection with dengue virus among international travelers. Arch Intern Med 1997 : 157 : 2367 2370.
57. Mairuhu AT, Wagenaar J, Brandjes DP, van Gop EC. Dengue: an arthropod-bourne disease of global importance. Eur J Clin Microbiol Infect Dis 2004 : 23 : 425 433.
58. Halstead SB. Dengue. Curr Opin Infect Dis 2002 : 15 : 471 476.
59. Lupi O, Bartlett BL, Haugen RN, et al. Tropical dermatology: tropical diseases caused by protozoa. J Am Acad Dermatol 2009 : 60 (6 897 928.
60. Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL. Chagas disease and the US blood supply. Curr Opin Infect Dis 2008 : 21 : 476 482.
61. Moncayo A, Ortiz Yanine MI. An update on Chagas disease (human American trypanosomiasis). Ann Trop Med Parasitol 2006 : 100 : 663 677.
62. Bern C, Montgomery SP, Herwarldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007 : 298 (18 2171 2181.
63. World Health Organization. Control of Chagas disease: second report of the WHO expert committee. Technical report series 905. Geneva, Switzerland : World Health Organization, 2003.
64. Diaz JH. Recognizing and reducing the risks of Chagas disease (American trypanosomiasis) in travelers. J Travel Med 2008 : 15 (3 184 195.
65. Rivera J, Hillis LD, Levine BD. Reactivation of cardiac Chagas disease in acquired immunodeficiency syndrome. Am J Cardiol 2004 : 94 : 1102 1103.
66. Vaidan AK, Weiss LM, Tanowitz HB. Chagas disease and AIDS. Kinetoplastid Biol Dis 2004 : 13 : 1 6.
67. Altclas J, Sinagra A, Jaimovich G, et al. Reactivation of chronic Chagas disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole. Transpl Infect Dis 1999 : 1 : 135 137.
68. Riarte A, Luna C, Sabatiello A, et al. Chagas disease in patients with kidney transplants: 7 years of experience, 1989-1996. Clin Infect Dis 1999 : 29 : 561 567.
69. Barrett MP, Burchmore FJ, Stitch A, et al. The trypanosomiases. Lancet 2003 : 362 : 1469 1480.
70. Apt W, Arribada A, Zulantay I, Sanchez G, Vargas SL, Rodriguez J. Itraconazole and allopurinol in the treatment of chronic American trypansomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years and follow up. Ann Trop Med Parasitol 2003 : 97 (1 23 29.
71. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004 : 27 : 305 318.
72. Khatami A, Firooz A, Gorouhi F, Dowlati Y. Treatment of acute old world cutaneous leishmaniasis: a systematic review of the randomized controlled trials. J Am Acad Dermatol 2007 : 335 : e1 e29.
73. Herwaldt BL. Leishmaniasis. Lancet 1999 : 354 : 1191 1199.
74. Mosleh IM, Geith E, Natsheh L, Schonian G, Abotteen N, Kharabsheh S. Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis. J Am Acad Dermatol 2008 : 58 : 617 624.
75. Palumbo E. Current treatment for cutaneous leishmaniasis: a review. Am J Ther 2009 : 16 (2 178 182.
76. Machado-Pinto J, Azulay RD. Leishmaniasis. In : Tyring SK, Lupi O, Hengge UR, eds. Tropical dermatology. New York : Elsevier Inc., 2006 : 41 48.
77. Rocha RD, Gontijo CM, Eloi-Santos SM, et al. Clinical value of anti-live Leishmania braziliensis immunoglobulin G subclasses detected by flow cytometry for diagnosing active localized cutaneous leishmaniasis. Trop Med Int Health 2006 : 11 : 156 166.
78. Spanakos G, Piperaki ET, Menounos PG, Tegos N, Flemetakis A, Vakalis NC. Detection and species identification of old world Leishmania in clinical samples using a PCR-based method. Trans R Soc Trop Med Hyg 2008 : 102 : 46 53.
79. Blum J, Desjeux P, Schwartz E, et al. Treatment of cutaneous leishmaniasis among travelers. J Antimicrob Chemother 2004 : 53 : 158 166.
80. Herwaldt B, Berman D. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992 : 46 : 521 524.
81. Alrajhi AA, Ibrahim EA, De Vol ED, Khairat M, Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002 : 346 : 891 895.
82. Momeni AZ, Jalayer T, Emamjomeh M, et al. Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study. Arch Dermatol 1996 : 132 (7 784 786.
83. Salmanpour R, Handjani F, Nouhpisheh MK. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate for the treatment of cutaneous leishmaniasis. J Dermatol Treat 2001 : 12 (3 159 162.
84. Soto J, Toledo J, Gutierrez P, et al. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis 2001 : 33 : e57 e61.
85. Firooz A, Khamesipour A, Ghoorchi M, et al. Imiquimod in combination with meglumine antimoniate for acute cutaneous leishmaniasis: a randomized assessor-blind controlled trial. Arch Dermatol 2006 : 142 : 1575 1579.